Review links cannabis use with later bipolar-spectrum outcomes
Cannabis use and subsequent onset of manic symptoms and bipolar disorder: A systematic review and meta-analysis.
AI Summary
This systematic review and meta-analysis asked whether cannabis use is associated with later bipolar disorder (BD) or manic/hypomanic symptoms. It combined 19 longitudinal observational studies of people without prior BD, including 6,960,517 participants overall; the comparisons were between people exposed and unexposed to cannabis. The pooled, unadjusted results showed an association with increased risk of subsequent BD (RR 2.46; 95% CI 1.57–3.84) and manic/hypomanic symptoms (RR 2.11; 95% CI 1.07–4.18).
The findings support an association, not proof that cannabis causes these outcomes. The review reported meaningful variation across studies, with moderator analyses identifying clinical and methodological sources of heterogeneity; study quality ratings ranged from good to high. This is an abstract-based summary: because the pooled estimates were unadjusted and the evidence is observational, the review cannot establish causation or determine an individual’s risk.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More Mental Health research papers you might find interesting.
Brain blood-flow reductions in acute anorexia follow a cortical hierarchy
CBD showed limited adaptive-functioning differences versus placebo in boys…
Resilience linked to depression outcomes and THC positivity
Explore More Research
Stay informed about the latest cannabis science.